OB/GYN Clinical Alert – October 1, 2018
October 1, 2018
View Issues
-
USPSTF Recommendation: Screening for Cervical Cancer
The U.S. Preventive Services Task Force (USPSTF) recently updated its recommendations for cervical cancer screening. Practitioners currently following guidelines published by ASCCP (and supported by ACOG) will not find any discrepancies in the new USPSTF position
-
Primary HPV Screening: Ready for Prime Time?
In this randomized, controlled trial of more than 25,000 women, participants with negative high-risk human papillomavirus testing at baseline had rates of CIN 3+ at 48 months that were lower compared to negative liquid-based cytology testing.
-
Intrauterine Devices and Cervical Cancer
In this case-control study, levonorgestrel IUD use was associated with a slightly increased rate of CIN 2 but not CIN 3. Copper IUD use was not associated with CIN 2 or CIN 3.
-
Vaginal Progesterone vs. Cerclage to Prevent Preterm Birth
SYNOPSIS: A recent indirect comparison meta-analysis has shown that vaginal progesterone is as useful in decreasing preterm birth and its associated adverse outcomes as cervical cerclage in patients with a history of preterm birth and short cervices.
-
Does Every Woman Deserve a High-volume Gynecologic Surgeon?
Generally, gynecologic surgical complications are higher with lower-volume surgeons.